The inhibition of HIF-1α simultaneously suppresses the immunosuppressive activity of myeloid-derived suppressor cells (MDSCs) and improves T-cell immunity in the tumor microenvironment (TME) [133,134,135]. The gene discussed is HIF1A; the disease is neoplasm.